Development of a World Health Organization International Reference Panel for different genotypes of hepatitis E virus for nucleic acid amplification testing.

Baylis, S. A. et al. (2019) Development of a World Health Organization International Reference Panel for different genotypes of hepatitis E virus for nucleic acid amplification testing. Journal of Clinical Virology, 119, pp. 60-67. (doi: 10.1016/j.jcv.2019.05.006) (PMID:31431408)

[img]
Preview
Text
194954.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

2MB

Abstract

Globally, hepatitis E virus (HEV) is a major cause of acute viral hepatitis. Epidemiology and clinical presentation of hepatitis E vary greatly by location and are affected by the HEV genotype. Nucleic acid amplification technique (NAT)-based assays are important for the detection of acute HEV infection as well for monitoring chronic cases of hepatitis E. The aim of the study was to evaluate a panel of samples containing different genotypes of HEV for use in nucleic NAT-based assays. The panel of samples comprises eleven different members including HEV genotype 1a (2 strains), 1e, 2a, 3b, 3c, 3e, 3f, 4c, 4g as well as a human isolate related to rabbit HEV. Each laboratory assayed the panel members directly against the 1 World Health Organization (WHO) International Standard (IS) for HEV RNA (6329/10) which is based upon a genotype 3 a strain. The samples for evaluation were distributed to 24 laboratories from 14 different countries and assayed on three separate days. Of these, 23 participating laboratories returned a total of 32 sets of data; 17 from quantitative assays and 15 from qualitative assays. The assays used consisted of a mixture of in-house developed and commercially available assays. The results showed that all samples were detected consistently by the majority of participants, although in some cases, some samples were detected less efficiently. Based on the results of the collaborative study the panel (code number 8578/13) was established as the "1st International Reference Panel (IRP) for all HEV genotypes for NAT-based assays" by the WHO Expert Committee on Biological Standardization. This IRP will be important for assay validation and ensuring adequate detection of different genotypes and clinically important sub-genotypes of HEV.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Thomson, Professor Emma
Authors: Baylis, S. A., Hanschmann, K.-M. O., Matsubayashi, K., Sakata, H., Roque-Afonso, A.-M., Kaiser, M., Corman, V. M., Kamili, S., Aggarwal, R., Trehanpati, N., Gärtner, T., Thomson, E. C., Davis, C. A., da Silva Filipe, A., Abdelrahman, T. T., Blümel, J., Terao, E., Pullirsch, D., Hottowy, B., Lewis-Ximenez, L. L., Pinto, M. A., Wang, Y., Huang, W., Zhao, C., Zheng, Z., Shih, J. W. K., Tang, Z.-M., Ji, W.-F., Izopet, J., Lhomme, S., Dubois, M., Roque-Afonso, A.-M., Gärtner, T., Schönborn, M., Beckort, C., Hess, M., Tillack, M., Brischke, D., Vollmer, T., Dreier, J., Wenzel, J., Klein, J., O’Riordan, J., Murphy, J., Boland, F., Pacini, B., Pisani, G., Simeoni, M., Fabi, S., Matsubayashi, K., Mizusawa, S., Uchida, S., Ekvärn, E., Hogema, B., Schuurman, T., Niesters, H., Schär, O., Ijaz, S., Dicks, S., Haywood, B., Mixson-Hayden, T., Kamili, S., Linnen, J., Ong, E., and Cory, R.
College/School:College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
Journal Name:Journal of Clinical Virology
Publisher:Elsevier
ISSN:1873-5967
ISSN (Online):1873-5967
Published Online:14 May 2019
Copyright Holders:Copyright © 2019 The Authors
First Published:First published in Journal of Clinical Virology 119:60-67
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record